Clinigen expands offering with AI for pharmacovigilance
The global specialist pharmaceutical services company, Clinigen, announced on Monday a strategic partnership with Tepsivo, a pioneering global digital Pharmacovigilance…
Pharmaceuticals, Biotechnology and Life Sciences
The global specialist pharmaceutical services company, Clinigen, announced on Monday a strategic partnership with Tepsivo, a pioneering global digital Pharmacovigilance…
AB2 Bio Ltd., a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven…
Moderna has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway…
Medix Biochemica, a global leader in the supply of critical raw materials for the in vitro diagnostics (IVD) industry, announced the acquisition of CANDOR Bioscience GmbH, a Germany-based developer and manufacturer of premium immunoassay solutions.
RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company has made an additional investment in the Series C financing round of Umoja Biopharma (“Umoja”), a clinical-stage biotechnology company aiming to develop in vivo cell therapies that improve the reach, effectiveness, and access of CAR T cell therapies in oncology and autoimmune treatments.
Celadon Pharmaceuticals announced Thursday collaboration with Valeos, a Danish pharmaceutical company, is active and it’s bringing results.
InflaRx N.V. announced Thursday that the European Commission (EC) has granted marketing authorization under exceptional circumstances for GOHIBIC® (vilobelimab) for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome
Santhera Pharmaceuticals said Thursday that Idorsia Pharmaceuticals has entered into a royalty monetization agreement with the R-Bridge Healthcare Fund in…
Together with partnering companies SCHOTT Pharma and Körber Pharma, Schreiner MediPharm is going to show how sustainable packaging design can combine waste and cost reduction with user convenience and patient safety.
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure system.